Compounds > nelfinavir
Page last updated: 2024-08-24

nelfinavir and Bilirubinemia

nelfinavir has been researched along with Bilirubinemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battista, C; Howell, BA; Mettetal, JT; Siler, SQ; Stahl, SH; Watkins, PB; Woodhead, JL; Yang, K1
Akoth, B; Angira, F; Masaba, R; Mills, LA; Minniear, TD; Ndivo, R; Oyaro, B; Peters, PJ; Polle, N; Thomas, TK; Zeh, C1

Other Studies

2 other study(ies) available for nelfinavir and Bilirubinemia

ArticleYear
Systems pharmacology modeling of drug-induced hyperbilirubinemia: Differentiating hepatotoxicity and inhibition of enzymes/transporters.
    Clinical pharmacology and therapeutics, 2017, Volume: 101, Issue:4

    Topics: Animals; Bilirubin; Carrier Proteins; Chemical and Drug Induced Liver Injury; Computer Simulation; Enzyme Inhibitors; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Indinavir; Liver; Mice; Mice, Knockout; Models, Biological; Nelfinavir; Pharmacokinetics; Rats; Rats, Gunn; Receptors, Chemokine; Systems Biology

2017
Rash, hepatotoxicity and hyperbilirubinemia among Kenyan infants born to HIV-infected women receiving triple-antiretroviral drugs for the prevention of mother-to-child HIV transmission.
    The Pediatric infectious disease journal, 2012, Volume: 31, Issue:11

    Topics: Adult; Aging, Premature; Anti-HIV Agents; Chemical and Drug Induced Liver Injury; Drug Eruptions; Female; HIV Infections; Humans; Hyperbilirubinemia; Infant, Newborn; Infectious Disease Transmission, Vertical; Kenya; Nelfinavir; Nevirapine; Pregnancy

2012